Related Articles
Protective effects of BMSCs in combination with erythropoietin in bronchopulmonary dysplasia-induced lung injury
Runx3 is a key modulator during the epithelial-mesenchymal transition of alveolar type II cells in animal models of BPD
Bone marrow mesenchymal stem cell implantation for the treatment of radioactivity‑induced acute skin damage in rats
Montelukast improves bronchopulmonary dysplasia by inhibiting epithelial‑mesenchymal transition via inactivating the TGF‑β1/Smads signaling pathway
Cord blood stem cell‑derived Angptl7 ameliorates the severity of bronchopulmonary dysplasia via anti‑inflammatory and proangiogenic effects